Evidence map›Paper›PMID 40353768›Full record

ArticleThe journal of physical chemistry. A2025

1,6-Diazapyrene: A Novel, Well-Defined, Small-Size Prototype System for Nitrogen-Containing PAHs.

Indranil Bhattacharjee, Liangxuan Wang, Nerea Gonzalez-Sanchis, Begoña Milián-Medina, Rafael Ballesteros, Reinhold Wannemacher, Rafael Ballesteros-Garrido, Johannes Gierschner

Abstract read
In one paragraph

Article in The journal of physical chemistry. A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Indranil BhattacharjeeMadrid Institute for Advanced Studies, IMDEA Nanoscience, C/Faraday 9, Ciudad Universitaria de Cantoblanco, Madrid 28049, Spain.
Liangxuan WangMadrid Institute for Advanced Studies, IMDEA Nanoscience, C/Faraday 9, Ciudad Universitaria de Cantoblanco, Madrid 28049, Spain.
Nerea Gonzalez-SanchisDepartment for Organic Chemistry, Faculty of Chemistry, University of Valencia, Burjassot, Valencia 46100, Spain.
Begoña Milián-MedinaDepartment for Physical Chemistry, Faculty of Chemistry, University of Valencia, Burjassot, Valencia 46100, Spain.
Rafael BallesterosDepartment for Organic Chemistry, Faculty of Chemistry, University of Valencia, Burjassot, Valencia 46100, Spain.
Reinhold WannemacherMadrid Institute for Advanced Studies, IMDEA Nanoscience, C/Faraday 9, Ciudad Universitaria de Cantoblanco, Madrid 28049, Spain.ORCID 0000-0001-7192-3556
Rafael Ballesteros-GarridoDepartment for Organic Chemistry, Faculty of Chemistry, University of Valencia, Burjassot, Valencia 46100, Spain.ORCID 0000-0002-8364-114X
Johannes GierschnerMadrid Institute for Advanced Studies, IMDEA Nanoscience, C/Faraday 9, Ciudad Universitaria de Cantoblanco, Madrid 28049, Spain.ORCID 0000-0001-8177-7919

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quest for nitrogen-doped (N-doped) polycyclic aromatic hydrocarbons (PAHs) requires well-defined prototype systems to understand the relationship between the structure and the resulting photophysical and photochemical properties. To this end, a novel, simple, and small compound, 1,6-diazapyrene, was synthesized. In-depth analysis, employing optical spectroscopy and (time-dependent) density functional theory, (TD-)DFT, elucidates the optical excitations on the basis of MO symmetry, energy, and topology considerations; the study further unveils the photophysical and photochemical deactivation kinetics after photoexcitation, revealing extreme changes against pyrene as well as against the well-known 2,7-diazapyrene isomer. The high sensitivity of the aza-substitution position to generate such changes is considered as highly relevant for the targeted design of N-doped PAHs in general.

Identifiers

PMID40353768
PMCPMC12128021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.